Experience

EuropaBio - the European Association for Bioindustries

• Belgium
• Biotechnology Research
• 1 - 100 Employee

• Member of the board of Europabio

  • Jun 2022 - Present

  In June 2022, I was elected to the Board of Europabio, the European Association for Bioindustries, with a mandate for two years (2022-2024) In June 2022, I was elected to the Board of Europabio, the European Association for Bioindustries, with a mandate for two years (2022-2024)



PTC Therapeutics, Inc.

• Biotechnology Research
• 700 & Above Employee

• Head of Government Affairs and Patient Advocacy, EMEA & APAC

  • Jan 2022 - Present

  I lead the development and implementation of PTC’s external affairs strategy and activities in the EMEA and APAC regions, across Government Affairs & Public Policy and Patient Advocacy working with both relevant PTC functions, cross functional launch teams and regional and country commercial teams. I am responsible for the advancement of PTC’s public policy priorities within relevant external forums that positively shape the regulatory and market access environment for advanced therapy… Show more I lead the development and implementation of PTC’s external affairs strategy and activities in the EMEA and APAC regions, across Government Affairs & Public Policy and Patient Advocacy working with both relevant PTC functions, cross functional launch teams and regional and country commercial teams. I am responsible for the advancement of PTC’s public policy priorities within relevant external forums that positively shape the regulatory and market access environment for advanced therapy medicinal products (ATMPs) and rare diseases in EMEA & APAC. I am responsible for leading the strategic direction and operational activities regarding PTC’s working with patient advocacy and other relevant patient-focused organizations to contribute to PTC Therapeutics mission “to make every day count for our patients” for the EMEA & APAC region.

• Head of Government Affairs and Public Policy, EMEA & APAC

  • Mar 2020 - Dec 2021

  I am responsible for the advancement of PTC's public policy priorities within the relevant external forums that positively shape the regulatory and market access environment for advanced cell and gene therapies and rare diseases in the EMEA and APC regions. I am a member of the EMEA And APAC leadership team, reporting to the SVP and GM EMEA & APAC.



DIA

• United States
• Pharmaceutical Manufacturing
• 200 - 300 Employee

• SVP and Managing Director EMEA, India & Singapore

  • May 2018 - Mar 2020

  I led the development and implementation of DIA’s strategy to grow membership, convening value, and impact to industry, government, patients, payer, and academia in the countries that comprise EMEA, and later on also India and Singapore. I was responsible for DIA’s program planning and operations, issue and content research and development, external relationships, financial delivery, and strategic outreach. In addition, I served as liaison to the executive level members within each… Show more I led the development and implementation of DIA’s strategy to grow membership, convening value, and impact to industry, government, patients, payer, and academia in the countries that comprise EMEA, and later on also India and Singapore. I was responsible for DIA’s program planning and operations, issue and content research and development, external relationships, financial delivery, and strategic outreach. In addition, I served as liaison to the executive level members within each organization that is or should be part of DIA, including national health authorities. Finally, I was responsible for leading a team of 17+ staff in the DIA’s EMEA regional office in Basel and 3 in DIA's India/Singapore office in Mumbai. Show less I led the development and implementation of DIA’s strategy to grow membership, convening value, and impact to industry, government, patients, payer, and academia in the countries that comprise EMEA, and later on also India and Singapore. I was responsible for DIA’s program planning and operations, issue and content research and development, external relationships, financial delivery, and strategic outreach. In addition, I served as liaison to the executive level members within each… Show more I led the development and implementation of DIA’s strategy to grow membership, convening value, and impact to industry, government, patients, payer, and academia in the countries that comprise EMEA, and later on also India and Singapore. I was responsible for DIA’s program planning and operations, issue and content research and development, external relationships, financial delivery, and strategic outreach. In addition, I served as liaison to the executive level members within each organization that is or should be part of DIA, including national health authorities. Finally, I was responsible for leading a team of 17+ staff in the DIA’s EMEA regional office in Basel and 3 in DIA's India/Singapore office in Mumbai. Show less



Biogen

• United States
• Biotechnology Research
• 700 & Above Employee

• Vice President Corporate Affairs EU+

  • Jun 2016 - Dec 2017

  - Lead the work of a European-wide Corporate Affairs Team (Public Policy, Government Affairs, Internal and External Communications and Patient Advocacy) team and help set the strategic direction for Biogen's external stakeholder engagement, globally. - Responsible for representing Biogen with European policy, patients advocacy and communication stakeholders, providing strategic input and guidance to Biogen's executive leadership on the impact of government policies. - Part of Biogen's… Show more - Lead the work of a European-wide Corporate Affairs Team (Public Policy, Government Affairs, Internal and External Communications and Patient Advocacy) team and help set the strategic direction for Biogen's external stakeholder engagement, globally. - Responsible for representing Biogen with European policy, patients advocacy and communication stakeholders, providing strategic input and guidance to Biogen's executive leadership on the impact of government policies. - Part of Biogen's European Leadership Team and interact with different business areas such as managed markets, regulatory, development, R&D, medical affairs, market access, commercial, new business development, and safety and compliance. - Report to Biogen's Senior Vice President Corporate Affairs, based in Boston.

• Vice President European Public Policy & Government Affairs

  • Jun 2015 - Jun 2016

  - Lead the work of a European-wide Public Policy & Government Affairs team and help set the strategic direction for Biogen's policy analysis and advocacy efforts globally. - Responsible for representing Biogen with European policy makers providing strategic input and guidance to Biogen's executive leadership on the impact of government policies. - Part of Biogen's European Leadership Team and interact with different business areas such as managed markets, regulatory, development, R&D… Show more - Lead the work of a European-wide Public Policy & Government Affairs team and help set the strategic direction for Biogen's policy analysis and advocacy efforts globally. - Responsible for representing Biogen with European policy makers providing strategic input and guidance to Biogen's executive leadership on the impact of government policies. - Part of Biogen's European Leadership Team and interact with different business areas such as managed markets, regulatory, development, R&D, medical affairs, market access, commercial, new business development, and safety and compliance. - Report to the Global Vice President of Public Policy & Government Affairs, based in Boston.



FTI Consulting

• United States
• Business Consulting and Services
• 700 & Above Employee

• Managing Director

  • Jan 2013 - May 2015

  Managing Director leading the EMEA region Public Affairs, Healthcare and Life Sciences offerings. Advising companies, industry organisations and consultancies on issues such as EU pharmaceutical legislation, healthcare stakeholder management, health policy issues (e.g. HTA, biosimilars, procurement, etc.), reputation management, communication and market access which are shaping the business of pharma and other healthcare related companies' environment today. We we believe that the… Show more Managing Director leading the EMEA region Public Affairs, Healthcare and Life Sciences offerings. Advising companies, industry organisations and consultancies on issues such as EU pharmaceutical legislation, healthcare stakeholder management, health policy issues (e.g. HTA, biosimilars, procurement, etc.), reputation management, communication and market access which are shaping the business of pharma and other healthcare related companies' environment today. We we believe that the combination of depth of industry knowledge, public affairs skills and unique range of advisory services in healthcare and life sciences will prove of real help for clients in the broadest sense in the healthcare space. Show less Managing Director leading the EMEA region Public Affairs, Healthcare and Life Sciences offerings. Advising companies, industry organisations and consultancies on issues such as EU pharmaceutical legislation, healthcare stakeholder management, health policy issues (e.g. HTA, biosimilars, procurement, etc.), reputation management, communication and market access which are shaping the business of pharma and other healthcare related companies' environment today. We we believe that the… Show more Managing Director leading the EMEA region Public Affairs, Healthcare and Life Sciences offerings. Advising companies, industry organisations and consultancies on issues such as EU pharmaceutical legislation, healthcare stakeholder management, health policy issues (e.g. HTA, biosimilars, procurement, etc.), reputation management, communication and market access which are shaping the business of pharma and other healthcare related companies' environment today. We we believe that the combination of depth of industry knowledge, public affairs skills and unique range of advisory services in healthcare and life sciences will prove of real help for clients in the broadest sense in the healthcare space. Show less



Merck Healthcare

• Germany
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Vice President Corporate Health Policy and Market Access

  • Sep 2009 - Dec 2012

  Leading Merck Serono's department responsible for 1) government affairs and health policy and 2) market access strategies and action for the company's current and future products, in Europe Leading Merck Serono's department responsible for 1) government affairs and health policy and 2) market access strategies and action for the company's current and future products, in Europe



Amgen

• United States
• Biotechnology Research
• 700 & Above Employee

• Director Government Affairs, Europe

  • Jan 2003 - Sep 2009

  Amgen (NASDAQ:AMGN), a biotechnology pioneer, discovers, develops and delivers innovative human therapeutics. Our medicines have helped millions of patients in the fight against cancer, kidney disease, rheumatoid arthritis and other serious illnesses. With a deep and broad pipeline of potential new medicines, we continue to advance science to serve patients. Amgen (NASDAQ:AMGN), a biotechnology pioneer, discovers, develops and delivers innovative human therapeutics. Our medicines have helped millions of patients in the fight against cancer, kidney disease, rheumatoid arthritis and other serious illnesses. With a deep and broad pipeline of potential new medicines, we continue to advance science to serve patients.



FleishmanHillard

• United States
• Public Relations and Communications Services
• 700 & Above Employee

• Executive Director

  • Jan 1995 - Jan 2003

  Heading the Food, Retail and Pharmaceuticals practice area in the Brussels office Heading the Food, Retail and Pharmaceuticals practice area in the Brussels office